Total Funding
80
64
Total FundingSeries C raised
Growth Score
-11 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
15705
BioTissue offers regenerative amniotic tissue-based products for ophthalmology, optometry, musculoskeletal, and wound care markets.
Amy H. Tseng: Founder and Board MemberPast Role: BioTissue, President, CEO & Founder- Michael Cornelius: Chief Financial Officer
About the Company
BioTissue is an innovative technology company that uses products derived from human amniotic and umbilical cord tissues. Its medical technology platform markets innovative amniotic and umbilical cord-based products, thereby enabling physicians to avail of enhanced regenerative healing technology in eye care, wound care, and orthopedics.
Tissuetech
was founded in 2001 and is headquartered in Miami, Florida.
Women Founded
